Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for non-invasive liquid biopsy by product
5.1 Kits and assays
5.1.1 Market size and forecast
5.2 Services
5.2.1 Market size and forecast

Part 6. Global market for non-invasive liquid biopsy by technology
6.1 Polymerase chain reaction (PCR)
6.1.1 Market size and forecast
6.2 Sequencing
6.2.1 Market size and forecast
6.3 Microarray
6.3.1 Market size and forecast
6.4 Others
6.4.1 Market size and forecast

Part 7. Global market for non-invasive liquid biopsy by sample
7.1 Faeces
7.1.1 Market size and forecast
7.2 Urine
7.2.1 Market size and forecast
7.3 Saliva
7.3.1 Market size and forecast
7.4 Others
7.4.1 Market size and forecast

Part 8. Global market for non-invasive liquid biopsy by application
8.1 Oncology
8.1.1 Market size and forecast
8.2 Reproductive health
8.2.1 Market size and forecast
8.3 Metabolic disorders
8.3.1 Market size and forecast
8.4 Others
8.4.1 Market size and forecast

Part 9. Global market for non-invasive liquid biopsy by region
9.1 Asia Pacific
9.1.1 Market size and forecast
9.2 Europe
9.2.1 Market size and forecast
9.3 North America
9.3.1 Market size and forecast
9.4 Rest of the World (RoW)
9.4.1 Market size and forecast

Part 10. Key competitor profiles
10.1 Analytik Jena AG
10.2 EXACT Sciences Corporation
10.3 Exosome Diagnostics, Inc. (Bio-Techne Corporation)
10.4 Lonza Group AG (Exosomics Siena S.p.A)
10.5 MDxHealth BV
10.6 Merck KGaA
10.7 OraSure Technologies, Inc.
10.8 PerkinElmer, Inc.
10.9 QIAGEN N.V.
10.10 Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY